Back to all stories

Trump secures drugmaker deals to cut Medicaid prices

President Donald Trump said Friday his administration reached agreements with nine additional major drugmakers — bringing 14 of the 17 largest firms on board — to a 'most-favored-nation' pricing initiative aimed at keeping Medicaid drug costs at or below prices in other high-income countries. The deals also include a combined $150 billion in new U.S. investment commitments and contributions of active pharmaceutical ingredients to a federal reserve, with a new TrumpRX.gov site set to launch in January 2026.

Health Business & Economy Local Government
This story is compiled from 1 source using AI-assisted curation and analysis. Original reporting is attributed below. Learn about our methodology.
Show source details & analysis

📊 Relevant Data

The monthly list price of Ozempic is $936 in the United States, compared to $169 in Japan and $83 in France. ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff)) ([Fierce Healthcare](https://www.fiercehealthcare.com/payers/list-prices-ozempic-wegovy-far-higher-us-peer-nations-kff))

List prices for Ozempic, Wegovy far higher in the US than in peer nations: KFF — Fierce Healthcare

Black and Latino adults had the highest rates of obesity at 49.9 percent and 45.6 percent respectively in 2025. ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/)) ([Trust for America's Health](https://www.tfah.org/report-details/state-of-obesity-report-2025/))

State of Obesity Report 2025 : Better Policies for a Healthier America — Trust for America's Health

Obesity disproportionately affects individuals from low socioeconomic backgrounds as well as racial and ethnic minority populations. ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/)) ([PMC (PubMed Central)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12277608/))

Sociodemographic Disparities in Obesity Prevalence Among Adults in the United States, 2017-2020 — PMC (PubMed Central)

In 2025, Hispanic people comprised 30.8% of Medicaid enrollees versus 19.7% of the population, and Black people 20.8% of enrollees. ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/)) ([Pew Research Center](https://www.pewresearch.org/short-reads/2025/06/24/what-the-data-says-about-medicaid/))

What the data says about Medicaid — Pew Research Center

Social determinants of health, such as where someone lives, and social inequities are primary drivers of obesity disparities. ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates)) ([George Mason University Public Health](https://publichealth.gmu.edu/news/2024-08/social-and-structural-factors-are-key-drivers-disparities-obesity-rates))

Social and structural factors are key drivers of disparities in obesity rates — George Mason University Public Health

📌 Key Facts

  • New signatories include Amgen, Boehringer Ingelheim, Bristol‑Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi
  • Total participating firms now 14 of the 17 largest global manufacturers, following earlier deals with Pfizer, AstraZeneca, Serrano, Novo Nordisk and Eli Lilly
  • $150B in combined commitments for U.S. manufacturing and R&D; some firms will donate APIs to the Strategic Active Pharmaceutical Ingredients Reserve

📰 Source Timeline (1)

Follow how coverage of this story developed over time

December 19, 2025